Loading…
Design, synthesis and biological evaluation of new tryptamine and tetrahydro-β-carboline-based selective inhibitors of CDK4
A library of selective inhibitors of CDK4 based on a tryptamine or β-carboline biphenyl carbonyl amides have been synthesised using the Suzuki–Miyaura cross-coupling reaction. The compounds were designed in view an observed π-stacking pocket within the active site of a CDK4 homology model. We presen...
Saved in:
Published in: | Bioorganic & medicinal chemistry 2008-08, Vol.16 (16), p.7728-7739 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A library of selective inhibitors of CDK4 based on a tryptamine or β-carboline biphenyl carbonyl amides have been synthesised using the Suzuki–Miyaura cross-coupling reaction. The compounds were designed in view an observed π-stacking pocket within the active site of a CDK4 homology model.
We present the design, synthesis and biological activity of a library of substituted (biphenylcarbonyl)-tryptamine and (biphenylcarbonyl)-tetrahydro-β-carboline compounds related to the natural product fascaplysin, as novel inhibitors of CDK4/cyclin D1. We show all these molecules, prepared using the Suzuki–Miyaura reaction, being selective inhibitors of CDK4 over CDK2. The most active compounds have a CDK4 IC
50 in the range 9–11
μM, three of them containing the
para-biphenyl plus
para-substituents supporting the existence of a π-stacking pocket within the active site of CDK4. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2008.07.002 |